Stock screenerAll disclosures →
EDGAR →
PMN
Conviction 42HealthcareScan · Thu, Jun 25, 2026PMN$10.52+2.73%
ResistanceSupportVol 14Insider buyVol MA14 17.64K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price10.52
Change+2.73%
Gap+2.44%
Rel volume2.33×
Avg volume20.68K
Avg $ vol211.14K
SMA 2010.24
SMA 5010.62
SMA 2008.79
Price vs 50-0.90%
Price vs 200+19.73%
MA stackmixed
50/200 cross—
Supertrenddown · 11.81
RSI (14)51
MACD hist0.11
MACD cross—
Stoch %K / %D72 / 70
ADX (14)18
+DI / −DI14 / 19
RSI divergence—
MACD divergence—
ATR %+6.22%
ADR %6.50%
52w high24.79
52w low0.2895
From 52w high-57.56%
Above 52w low+3533.85%
New 52w highNo
SqueezeOn · 42d
Bollinger width17.43%
%B0.66
Donchian pos62.86%
Donchian high11.37
Donchian low9.09
AVWAP (52w high)13.61
vs AVWAP high-22.70%
AVWAP (52w low)13.41
vs AVWAP low-21.55%
OBV trendFlat
Chaikin MF (20)-0.27
Today vs 20d2.33×
Avg vol (14d)17.64K
Avg vol (20d)20.68K
Avg $ vol (20d)211.14K
Market cap94.34M
RS 3m (vs SPY)-53.51%
RS 6m (vs SPY)+12.03%
RS line new highNo
Trend template3/8
Technical rank70.4
1 week+1.35%
1 month+1.54%
3 months-33.63%
6 months+29.40%
1 year+2069.07%
YTD+47.44%
P/E-2.38
P/B1.55
P/S—
P/FCF-3.35
EPS-22.61
Div yield—
ROE-65.42%
ROA-58.92%
Debt/Eq0.00
Current9.92
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-1529.33%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value30.53M
Revenue—
Net income-8.24M
Gross profit—
Free cash flow-28.12M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out8.97M
Employees11
ListedFri, Sep 30, 2005
Free float7.88M
Float %87.9%
Short interest188.79K
Days to cover8.6d
Short volume8.3%
Squeeze score45 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank70.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.45
Support9.09
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PMN
No recent disclosed trades by Congress in PMN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PMN · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Mandel-Brehm Josh Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
Kaplan Johanne Chief Development Officer · Option (right to buy) · 2026-05-20 | Grant | 50K | $0 | 2026-05-20 | 2026-05-22 |
WYMAN WILLIAM W Director · Option (right to buy) · 2026-05-20 | Grant | 5.5K | $0 | 2026-05-20 | 2026-05-22 |
Warma Neil K Chief Executive Officer · Option (right to buy) · 2026-05-20 | Grant | 160K | $0 | 2026-05-20 | 2026-05-22 |
Williams Eugene Director · Option (right to buy) · 2026-05-20 | Grant | 5.5K | $0 | 2026-05-20 | 2026-05-22 |
Milbury Max A. Principal Accounting Officer · Option (right to buy) · 2026-05-20 | Grant | 18.17K | $0 | 2026-05-20 | 2026-05-22 |
Alex Slanix Paul Director · Option (right to buy) · 2026-05-20 | Grant | 5.5K | $0 | 2026-05-20 | 2026-05-22 |
Shafmaster Madge K. Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
WYMAN WILLIAM W Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
Williams Eugene Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
SEC filings
EDGAR filings in PMN
No recent SEC filings on file for PMN.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.